In addition, the expression of TLR4 was the highest among other TLRs in human breast cancer, and TLR4 activation could subsequently activate nuclear factor-κB (NF-κB) and produce pro-inflammatory cytokines, ultimately stimulating inflammation (Yang et al., 2010; Eskiler et al., 2019). Here, NFKB1 is linked to breast cancer.